Odyssey Therapeutics, Inc.
ODTX· Nasdaq
When Odyssey Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
6 quarters. Mar 31, 2025 to Sep 30, 2026. USD.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 4, 2026 · pre-market | Nov 4, 2026 | 35 d | 10-Q | |||||
Odyssey Therapeutics, Inc. · CIK 1882782 · Engraved from SEC EDGAR
| $0.00 |
| −100.0% |
| -$1.10 |
| 9.8% |
| Q2 2026 | Jun 30, 2026 | Aug 4, 2026 · pre-market | Aug 6, 2026 | 37 d | 10-Q | $0.00 | −100.0% | -$1.74 | +10.6% |
|---|
| Q1 2026 | Mar 31, 2026 | Jun 17, 2026 · after-hours | Jun 17, 2026 | 78 d | 10-Q | $0.00 | −100.0% | -$6.77 | +3.6% |
|---|
| FY 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2025 | Sep 30, 2025 | — | — | — | — | $99.00K | — | -$7.78 | — | |
| Q2 2025 | Jun 30, 2025 | — | — | — | — | $959.00K | — | -$29.54 | — | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | $1.92M | — | -$39.37 | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The stock’s move from the last close before each release to the first close after it, over the last 3 releases. Largest: +10.6% after Q2 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.